Skip to main content

Rensselaer Polytechnic Institute (RPI)

Home  »  News  »  Research

Research News at Rensselaer

Rensselaer Polytechnic Institute Team to Conduct Research at Tetris Championship

October 19, 2017 - A team from Rensselaer will attend the Classic Tetris World Championship in Portland, Oregon, Oct. 20-22, to collect data from the world’s best Tetris players.

Extreme Light Trapping

October 18, 2017 - Shawn-Yu Lin, professor of physics, applied physics, and astronomy at Rensselaer Polytechnic Institute, has built a nanostructure whose crystal lattice bends light as it enters the material and directs it in a path parallel to the surface, known as “parallel to interface refraction.” 

World-Leading Expert on Humanitarian Logistics From Rensselaer To Discuss Puerto Rico’s Supply Chain Struggles To Disperse Aid

October 5, 2017 - Troy, N.Y. — Two weeks after Hurricane Maria wrecked devastation on Puerto Rico, destroying the power grid and leaving millions without access to necessities, distributing aid remains an issue. Extreme events pose serious logistical challenges to emergency and aid organizations active in preparation, response, and recovery operations, as the disturbances they bring about turn normal conditions into chaos. On Thursday, October 5, José Holguín-Veras, the William H.

Rensselaer Biologist Sandra Nierzwicki-Bauer Named to NYS Drinking Water Quality Council

October 4, 2017 - Sandra Nierzwicki-Bauer, professor of biological sciences and associate director of the Darrin Fresh Water Institute at Rensselaer Polytechnic Institute, has been appointed to the Drinking Water Quality Council by New York State Governor Andrew M. Cuomo. The council will guide New York’s actions to ensure that all communities across the state have access to clean drinking water.

School of Engineering To Host Sixth Annual National Manufacturing Day

October 4, 2017 - Troy, N.Y. – On Friday, Oct. 6, in celebration of Manufacturing Day, the School of Engineering at Rensselaer Polytechnic Institute will open doors to students, educators, businesspeople, media, politicians, and regional manufacturers to share Rensselaer’s vision and expertise in innovative education and research in manufacturing, showcase facilities, and highlight career opportunities in field. Prior to the start of the program, members of the campus and local community are invited to view the 7:30 a.m.

Understanding Heart Disease

October 2, 2017 - The Center for Biotechnology and Interdisciplinary Studies was buzzing with activity over the summer, with more than 200 undergraduate and graduate students conducting research that will impact the global challenges facing humanity. In the lab of Douglas Swank, associate professor of biological sciences, researchers are using Drosophila (commonly known as the fruit fly) as a model organism to unravel some of the biggest mysteries of the human heart.

Confronting Dementia From Lab to Bedside

September 27, 2017 - To bolster the connections between benchside and bedside, the National Institutes of Health National Institute on Aging has awarded Rensselaer Polytechnic Institute a five-year $1.5 million training grant to support a new Alzheimer’s Disease Clinical and Translational Research Training Program. 

Showcasing Innovative Architectural Design

September 21, 2017 - New work from the School of Architecture that explores sustainable building practices, new design and fabrication strategies, architectural acoustics, and the integration of new technologies will be showcased at the World Maker Faire New York.

Research Showcase Focuses on Biotechnology and Life Sciences

September 8, 2017 - The fourth annual Rensselaer Research Showcase on August 23 offered government and private sector research partners an opportunity to learn more about insights emerging from research in biotechnology and the life sciences, and the current climate for the biopharmaceutical economy that work supports.

Synthetic Version of Popular Anticoagulant Poised for Clinical Trials

September 6, 2017 - A synthetic version of low molecular weight heparin is poised for clinical trials and development as a drug for patients with clotting disorders, and those undergoing procedures such as kidney dialysis, heart bypass surgery, stent implantation, and knee and hip replacement. 

Pages